Centralised Procurement System To Be Set Up At AIIMS Delhi

New Delhi : The AIIMS here will establish a centralised procurement system to streamline the procurement process and promote uniformity and transparency. At present, a decentralised procurement system exists wherein various departments and stores perform respective procurements as per demand, according to an office memorandum issued this week.

The establishment of a centralised nodal point for procurement will help facilitate coordination between different stores procuring various items, AIIMS Director Dr M Srinivas said.

It is proposed to create a pool of faculty members nominated by heads of various departments, including department of hospital administration and clinical departments, and a roster will be created to rotate the procurement in charge (procurement) and officer in charge (OIC procurement) annually for the next five years.

The OIC-procurement will be a clinical department faculty in the rank of professor or additional professor, and provide inputs regarding clinical perspectives.

The procurement will be a faculty from the department of hospital as the nodal point for various procurement related matters concerning the institute as well as provide inputs regarding administrative and procedural perspectives.

The move is aimed at streamlining the procurement process, promoting efficiency as well as ensuring transparency, Dr Srinivas said.

Related Posts

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit

Pharma companies in a flux over Trump’s 200% tariff move on generics

Pharma companies in a flux over Trump’s 200% tariff move on generics

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

Noida Raid Uncovers Suspected ₹2.48-Crore Diversion of Life-Saving Medicines; Probe Expands Into Government Supply Chain and Interstate Network

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’

CDSCO Directs Safety Updates for Ibuprofen and Aceclofenac Over Risk of ‘Fixed Drug Eruption’